Related Experiment Video
Updated: Jul 30, 2026

Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
Symptomatic cardiac amyloidosis in an American family
Insights
This study highlights a family with frequent cardiac amyloidosis. Echocardiography and scintigraphy are key for diagnosing this infiltrative cardiomyopathy in relatives.
Area of Science:
- Cardiology
- Genetics
- Medical Imaging
Background:
- Cardiac amyloidosis is an infiltrative cardiomyopathy with a significant genetic component.
- Early detection is crucial for managing familial cases and improving patient outcomes.
Observation:
- A report on an American family with a high incidence of symptomatic cardiac amyloidosis across four siblings.
- The study focuses on identifying affected individuals within the family unit.
Findings:
- Echocardiography demonstrated characteristic findings of cardiac amyloidosis.
- Technetium pyrophosphate myocardial scintigraphy proved effective in detecting amyloid deposition in the myocardium.
- These imaging modalities were instrumental in diagnosing the infiltrative cardiomyopathy within the family.
Implications:
- Highlights the importance of genetic screening and advanced cardiac imaging in families with a history of cardiac amyloidosis.
- Suggests a familial predisposition that warrants proactive diagnostic approaches.
- Emphasizes the role of echocardiography and scintigraphy as valuable tools for early and accurate diagnosis of infiltrative cardiomyopathy.
Abstract:
This report describes an American family with a high incidence of symptomatic cardiac amyloidosis among four siblings, and explores the role of echocardiography and technetium pyrophosphate myocardial scintigraphy in the detection of this infiltrative cardiomyopathy within the involved family.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Myocarditis II: Clinical Features and Diagnostic Tests
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

